Clinical trial · Observational
Establishment and Standardization of a Platform for In-depth Tumour Profiling (TUPRO) in Patients With Advanced and Metastatic High-Grade Adenocarcinoma of Ovarian, Tubal or Peritoneal Origin (TUPRO-Gyn)
Establishment and Standardization of a Platform for In-depth Tumour Profiling (TUPRO) in Patients With Advanced and Metastatic High-Grade Adenocarcinoma of Ovarian, Tubal or Peritoneal Origin - a Prospective, Multi-centre Human Research Ordinance Research Project / Category A
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The aim of this prospective, multi-centre, exploratory research project is the establishment of a platform for in-depth tumour profiling in patients with advanced and metastatic High-Grade Adenocarcinoma (HGAC) of ovarian, tubal or peritoneal origin.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Adenocarcinoma of Ovary | Ovarian Adenocarcinoma | ALIAS | 0.90 |
| Adenocarcinoma, Tubular | Tubular Adenocarcinoma | ONTOLOGY_EXACT | 0.90 |
| Peritoneal Cancer | Malignant Peritoneal Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (0)
Data not yet available
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (16)
- measure
- Sample Processing and Report Generation (1)
- timeFrame
- Through study completion, an average of 1 year
- description
- \- Number of samples with sufficient material and quality for intended analysis.
- measure
- Sample Processing and Report Generation (2)
- timeFrame
- Through study completion, an average of 1 year
- description
- \- Number of successfully processed samples per technology, with quality checks passed and interpretable results generated.
- measure
- Sample Processing and Report Generation (3)
- timeFrame
- Through study completion, an average of 1 year
- description
- \- Successful data transfers into the research data management system, ensuring results are timely for inclusion in the molecular research report.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Age ≥ 18 years * Eastern Cooperative Oncology Group performance status score ≤ 2 (not bedridden for more than 50% of waking hours) * Primary or recurrent HGAC of ovarian, tubal or peritoneal origin International Federation of Gynecology and Obstetrics (FIGO) stage III or IV * Written informed consent according to national legal and regulatory requirements prior to any project specific procedures Exclusion Criteria: * Any other serious underlying medical, psychiatric, psychological, familial or geographical condition, which in the judgment of the project leader may interfere with the project or affect patient compliance * Legal incompetence
References
Publications (0)
Data not yet available